Daniel R. Whiten
YOU?
Author Swipe
View article: Neuroserpin and transthyretin are extracellular chaperones that preferentially inhibit amyloid formation
Neuroserpin and transthyretin are extracellular chaperones that preferentially inhibit amyloid formation Open
Neuroserpin preferentially inhibits amyloid formation; a 14-mer region in neuroserpin is implicated in binding to amyloid.
View article: PINK1 signalling in neurodegenerative disease
PINK1 signalling in neurodegenerative disease Open
PTEN-induced kinase 1 (PINK1) impacts cell health and human pathology through diverse pathways. The strict processing of full-length PINK1 on the outer mitochondrial membrane populates a cytoplasmic pool of cleaved PINK1 (cPINK1) that is c…
View article: A Platform for Site‐Specific DNA‐Antibody Bioconjugation by Using Benzoylacrylic‐Labelled Oligonucleotides
A Platform for Site‐Specific DNA‐Antibody Bioconjugation by Using Benzoylacrylic‐Labelled Oligonucleotides Open
Many bioconjugation strategies for DNA oligonucleotides and antibodies suffer limitations, such as site‐specificity, stoichiometry and hydrolytic instability of the conjugates, which makes them unsuitable for biological applications. Here,…
View article: A Platform for Site‐Specific DNA‐Antibody Bioconjugation by Using Benzoylacrylic‐Labelled Oligonucleotides
A Platform for Site‐Specific DNA‐Antibody Bioconjugation by Using Benzoylacrylic‐Labelled Oligonucleotides Open
Many bioconjugation strategies for DNA oligonucleotides and antibodies suffer limitations, such as site‐specificity, stoichiometry and hydrolytic instability of the conjugates, which makes them unsuitable for biological applications. Here,…
View article: Single cell morphology distinguishes genotype and drug effect in Hereditary Spastic Paraplegia
Single cell morphology distinguishes genotype and drug effect in Hereditary Spastic Paraplegia Open
View article: Imaging protein aggregates in the serum and cerebrospinal fluid in Parkinson’s disease
Imaging protein aggregates in the serum and cerebrospinal fluid in Parkinson’s disease Open
Aggregation of α-synuclein plays a key role in the development of Parkinson’s disease. Soluble aggregates are present not only within human brain but also the CSF and blood. Characterizing the aggregates present in these biofluids may prov…
View article: Alpha Synuclein only Forms Fibrils In Vitro when Larger than its Critical Size of 70 Monomers
Alpha Synuclein only Forms Fibrils In Vitro when Larger than its Critical Size of 70 Monomers Open
The aggregation of α‐synuclein into small soluble aggregates and then fibrils is important in the development and spreading of aggregates through the brain in Parkinson's disease. Fibrillar aggregates can grow by monomer addition and then …
View article: Tumour necrosis factor induces increased production of extracellular amyloid-β- and α-synuclein-containing aggregates by human Alzheimer’s disease neurons
Tumour necrosis factor induces increased production of extracellular amyloid-β- and α-synuclein-containing aggregates by human Alzheimer’s disease neurons Open
In addition to increased aberrant protein aggregation, inflammation has been proposed as a key element in the pathogenesis and progression of Alzheimer’s disease. How inflammation interacts with other disease pathways and how protein aggre…
View article: Soluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer’s disease progression
Soluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer’s disease progression Open
View article: O3‐01‐03: MECHANISM OF TOXICITY INDUCED BY AMYLOID‐BETA AGGREGATES CHANGES DURING THE PROGRESSION OF ALZHEIMER'S DISEASE
O3‐01‐03: MECHANISM OF TOXICITY INDUCED BY AMYLOID‐BETA AGGREGATES CHANGES DURING THE PROGRESSION OF ALZHEIMER'S DISEASE Open
Misfolding and aggregation of proteins and peptides is a central pathological and biochemical event shared by many neurodegenerative conditions including Alzheimer's diseases (AD) Soluble aggregated forms of amyloid beta (Aβ) are believed …
View article: Secondary nucleation and elongation occur at different sites on Alzheimer’s amyloid-β aggregates
Secondary nucleation and elongation occur at different sites on Alzheimer’s amyloid-β aggregates Open
Chaperone regulation of individual microscopic events in Aβ42 aggregation reveals the nature of active sites on amyloid fibrils.
View article: ADSoluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer’s disease progression
ADSoluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer’s disease progression Open
Soluble aggregates of amyloid-β (Aβ) have been associated with neuronal and synaptic loss in Alzheimer’s disease (AD). However, despite significant recent progress, the mechanisms by which these aggregated species contribute to disease pro…
View article: Different soluble aggregates of Aβ42 can give rise to cellular toxicity through different mechanisms
Different soluble aggregates of Aβ42 can give rise to cellular toxicity through different mechanisms Open
Protein aggregation is a complex process resulting in the formation of heterogeneous mixtures of aggregate populations that are closely linked to neurodegenerative conditions, such as Alzheimer’s disease. Here, we find that soluble aggrega…
View article: Quantifying Co-Oligomer Formation by α-Synuclein
Quantifying Co-Oligomer Formation by α-Synuclein Open
Small oligomers of the protein α-synuclein (αS) are highly cytotoxic species associated with Parkinson's disease (PD). In addition, αS can form co-aggregates with its mutational variants and with other proteins such as amyloid-β (Aβ) and t…
View article: Nanoscopic Characterisation of Individual Endogenous Protein Aggregates in Human Neuronal Cells
Nanoscopic Characterisation of Individual Endogenous Protein Aggregates in Human Neuronal Cells Open
The aberrant misfolding and subsequent conversion of monomeric protein into amyloid aggregates characterises many neurodegenerative disorders, including Parkinson's and Alzheimer's diseases. These aggregates are highly heterogeneous in str…
View article: α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson’s disease
α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson’s disease Open
View article: Single-Molecule Characterization of the Interactions between Extracellular Chaperones and Toxic α-Synuclein Oligomers
Single-Molecule Characterization of the Interactions between Extracellular Chaperones and Toxic α-Synuclein Oligomers Open
View article: Shedding light on aberrant interactions – a review of modern tools for studying protein aggregates
Shedding light on aberrant interactions – a review of modern tools for studying protein aggregates Open
The link between protein aggregation and neurodegenerative disease is well established. However, given the heterogeneity of species formed during the aggregation process, it is difficult to delineate details of the molecular events involve…
View article: The small heat shock protein Hsp27 binds α-synuclein fibrils, preventing elongation and cytotoxicity
The small heat shock protein Hsp27 binds α-synuclein fibrils, preventing elongation and cytotoxicity Open
Proteostasis, or protein homeostasis, encompasses the maintenance of the conformational and functional integrity of the proteome and involves an integrated network of cellular pathways. Molecular chaperones, such as the small heat shock pr…
View article: Inhibiting the Ca2+ Influx Induced by Human CSF
Inhibiting the Ca2+ Influx Induced by Human CSF Open
View article: Clusterin protects neurons against intracellular proteotoxicity
Clusterin protects neurons against intracellular proteotoxicity Open
It is now widely accepted in the field that the normally secreted chaperone clusterin is redirected to the cytosol during endoplasmic reticulum (ER) stress, although the physiological function(s) of this physical relocation remain unknown.…
View article: Flow cytometric measurement of the cellular propagation of TDP-43 aggregation
Flow cytometric measurement of the cellular propagation of TDP-43 aggregation Open
Amyotrophic lateral sclerosis is a devastating neuromuscular degenerative disease characterized by a focal onset of motor neuron loss, followed by contiguous outward spreading of pathology including TAR DNA-binding protein of 43 kDa (TDP-4…
View article: Flow Cytometric Measurement of the Cellular Propagation of TDP-43 aggregation
Flow Cytometric Measurement of the Cellular Propagation of TDP-43 aggregation Open
Amyotrophic lateral sclerosis is a devastating neuromuscular degenerative disease characterised by a focal onset of motor neuron loss, followed by contiguous outward spreading of pathology including TAR DNA-binding protein of 43 kDa (TDP-4…
View article: Flow cytometric measurement of the cellular propagation of TDP-43 aggregation
Flow cytometric measurement of the cellular propagation of TDP-43 aggregation Open
Amyotrophic lateral sclerosis is a devastating neuromuscular degenerative disease characterized by a focal onset of motor neuron loss, followed by contiguous outward spreading of pathology including TAR DNA-binding protein of 43 kDa (TDP-4…
View article: Rapid flow cytometric measurement of protein inclusions and nuclear trafficking
Rapid flow cytometric measurement of protein inclusions and nuclear trafficking Open
View article: The Role of clusterin in motor neuron disease and the molecular mechanism of its action
The Role of clusterin in motor neuron disease and the molecular mechanism of its action Open
Amyotrophic lateral sclerosis (ALS) is a currently untreatable disease characterised by the progressive loss of motor neurons. Death typically occurs as a result of respiratory failure within just 3 years of diagnosis. Aberrant protein agg…